<DOC>
	<DOCNO>NCT01926366</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study single multiple ascend dosage level AZD6423 healthy volunteer . The study include 28-day screening period , in-house period AZD6423 placebo administer IV , 4- 10-day follow-up period discharge .</brief_summary>
	<brief_title>AZD6423 SAD/MAD Study Healthy Volunteers</brief_title>
	<detailed_description>In Part 1 study ( single ascend dose portion ) , approximately 40 subject randomly assign . Eight ( 8 ) subject randomize 5 dosage-level cohort ( AZD6423 placebo ) . Within cohort , 6 subject randomize receive AZD6423 2 subject randomize receive placebo . Each subject receive one dose either AZD6423 placebo Day 1 . In Part 2 study ( multiple ascend dose portion ) , approximately 24 subject randomly assign . Eight ( 8 ) subject randomize 3 dosage-level cohort . Within cohort , 6 subject randomize receive AZD6423 2 subject randomize receive placebo . Each subject receive three dos either AZD6423 placebo .</detailed_description>
	<criteria>1 . Subjects must understand nature study must provide sign dated write informed consent accordance local regulation conduct studyspecific procedure . 2 . All male subject biologically capable child must agree commit use reliable method birth control duration study 15 day dose administration . A male subject consider biologically capable child even sexual partner sterile use contraceptive . 3 . Subjects must body mass index ( BMI ) 19 30 , inclusive weigh 50kg 100kg inclusive . 4 . Subjects must fluent English . 1 . A history presence clinically significant hepatic , renal , gastrointestinal , cardiovascular , endocrine , respiratory , immunologic , hematologic , dermatologic , neurologic abnormality . 2 . A clinically significant abnormality physical examination , neurological examination , EEG , ECG , vital sign laboratory evaluation screen screen dose administration . 3 . A history seizure . 4 . A history head trauma , include closed head injury loss consciousness . 5 . Any history suicide attempt suicidal behavior , , opinion investigator , clinically significant risk suicide violent behavior . 6 . Urine drug screen positive drug abuse 7 . A family history schizophrenia , schizoaffective disorder , psychosis first degree relative .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>